Treatment of insulin resistance in diabetes mellitus
- 19 April 2004
- journal article
- review article
- Published by Elsevier BV in European Journal of Pharmacology
- Vol. 490 (1-3), 135-146
- https://doi.org/10.1016/j.ejphar.2004.02.051
Abstract
No abstract availableKeywords
This publication has 93 references indexed in Scilit:
- Inflammation in the Prediabetic State Is Related to Increased Insulin Resistance Rather Than Decreased Insulin SecretionCell Metabolism, 2003
- Pioglitazone reduces neointimal tissue proliferation after coronary stent implantation in patients with type 2 diabetes mellitus: an intravascular ultrasound scanning studyAmerican Heart Journal, 2003
- Differential Effects of Metformin and Troglitazone on Cardiovascular Risk Factors in Patients With Type 2 DiabetesDiabetes Care, 2002
- Control of Vascular Cell Proliferation and Migration by PPAR-γDiabetes Care, 2001
- Insulin Resistance and Its Treatment by ThiazolidinedionesRecent Progress in Hormone Research, 2001
- Plasminogen-Activator Inhibitor Type 1 and Coronary Artery DiseaseNew England Journal of Medicine, 2000
- The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitusJCI Insight, 1999
- Impact of Adipose Tissue on Plasma Plasminogen Activator Inhibitor-1 in Dieting Obese WomenArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)The Lancet, 1998
- Visceral fat as a main determinant of plasminogen activator inhibitor 1 level in womenInternational Journal of Obesity, 1998